-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on Sana Biotechnology, Lowers Price Target to $11

Benzinga·11/16/2026 18:52:04
Listen to the news
Citigroup analyst Samantha Semenkow maintains Sana Biotechnology (NASDAQ:SANA) with a Buy and lowers the price target from $12 to $11.